Blind deconvolution estimation of an arterial input function for small animal DCE-MRI.
暂无分享,去创建一个
Aleš Hampl | Michal Bartoš | Radovan Jiřík | Jiří Kratochvíla | Zenon Starčuk | Torfinn Taxt | Ondřej Macíček | Karel Souček | Eva Dražanová | Lucie Krátká | T. Taxt | A. Hampl | Z. Starcuk | K. Souček | R. Jiřík | E. Drazanova | M. Bartoš | J. Kratochvíla | Ondrej Macicek | Lucie Krátká | Z. Starčuk | E. Dražanová | Ondřej Macíček | Michal Bartoš
[1] L. Nabors,et al. High‐resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI , 2009, Magnetic resonance in medicine.
[2] Michal Bartoš,et al. The precision of DCE-MRI using the tissue homogeneity model with continuous formulation of the perfusion parameters. , 2014, Magnetic resonance imaging.
[3] Zhuxian Zhou,et al. Gadolinium-based contrast agents for magnetic resonance cancer imaging. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[4] D. Drost,et al. Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents , 2000, Journal of magnetic resonance imaging : JMRI.
[5] J. Bussink,et al. Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI. , 2018, Cancer research.
[6] Joël Mispelter,et al. Simultaneous dynamic T1 and T2* measurement for AIF assessment combined with DCE MRI in a mouse tumor model , 2007, Magnetic Resonance Materials in Physics, Biology and Medicine.
[7] A. Jackson,et al. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors , 2000, Journal of magnetic resonance imaging : JMRI.
[8] Steven Sourbron,et al. T2*‐relaxivity contrast imaging: First results , 2013, Magnetic Resonance in Medicine.
[9] Thomas E. Yankeelov,et al. Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation , 2012, Pharmaceutics.
[10] Marleen Verhoye,et al. Assessment of the neovascular permeability in glioma xenografts by dynamic T1 MRI with Gadomer‐17 , 2002, Magnetic Resonance in Medicine.
[11] Odd Helge Gilja,et al. Blind deconvolution in dynamic contrast-enhanced MRI and ultrasound , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[12] T. Taxt,et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma , 2011, Proceedings of the National Academy of Sciences.
[13] L. Delrue,et al. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights , 2011, Magnetic Resonance Materials in Physics, Biology and Medicine.
[14] D M Shames,et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. , 1998, AJR. American journal of roentgenology.
[15] Alan Jackson,et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology , 2005 .
[16] T. Taxt,et al. Using Single-Channel Blind Deconvolution to Choose the Most Realistic Pharmacokinetic Model in Dynamic Contrast-Enhanced MR Imaging , 2015 .
[17] R. Reed,et al. Compliance of the interstitial space in rats. I. Studies on hindlimb skeletal muscle. , 1981, Acta physiologica Scandinavica.
[18] Michal Bartoš,et al. Distributed capillary adiabatic tissue homogeneity model in parametric multi‐channel blind AIF estimation using DCE‐MRI , 2016, Magnetic resonance in medicine.
[19] T S Koh,et al. Issues of discontinuity in the impulse residue function for deconvolution analysis of dynamic contrast‐enhanced MRI data , 2011, Magnetic resonance in medicine.
[20] Edward V R Dibella,et al. Model‐based blind estimation of kinetic parameters in dynamic contrast enhanced (DCE)‐MRI , 2009, Magnetic resonance in medicine.
[21] Hui Tang,et al. Measurement of Murine Single‐Kidney Glomerular Filtration Rate Using Dynamic Contrast‐Enhanced MRI , 2018, Magnetic resonance in medicine.
[22] J. Bankson,et al. Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling , 2010, NMR in biomedicine.
[23] T. Taxt,et al. Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] Steven P Sourbron,et al. Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.
[25] J. Gore,et al. A quantitative comparison of the influence of individual versus population‐derived vascular input functions on dynamic contrast enhanced‐MRI in small animals , 2012, Magnetic resonance in medicine.
[26] A. D. Hendriks,et al. Quantitative first‐pass perfusion MRI of the mouse myocardium , 2013, Magnetic resonance in medicine.
[27] Matthias C. Schabel. A unified impulse response model for DCE‐MRI , 2012, Magnetic resonance in medicine.
[28] K. B. Larson,et al. Tracer-Kinetic Models for Measuring Cerebral Blood Flow Using Externally Detected Radiotracers , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[29] D L Buckley,et al. Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability , 2012, Physics in medicine and biology.
[30] Edward V R DiBella,et al. A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results , 2010, Physics in medicine and biology.
[31] Johannes Buurman,et al. Effects of reference tissue AIF derived from low temporal resolution DCE-MRI data on pharmacokinetic parameter estimation , 2010 .
[32] Klaas Nicolay,et al. A novel approach to tracer‐kinetic modeling for (macromolecular) dynamic contrast‐enhanced MRI , 2016, Magnetic Resonance in Medicine.
[33] A. Jackson,et al. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[34] R. Brasch,et al. Effect of varying the molecular weight of the MR contrast agent Gd‐DTPA‐polylysine on blood pharmacokinetics and enhancement patterns , 1994, Journal of magnetic resonance imaging : JMRI.
[35] Brian Middleton,et al. Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts. , 2003, Magnetic resonance imaging.
[36] T S Koh,et al. The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. , 2001, Physics in medicine and biology.
[37] D. Buckley,et al. Precision in measurements of perfusion and microvascular permeability with T1‐weighted dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[38] Ting-Yim Lee,et al. An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[39] R. Lucht,et al. Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.